Get the Stockscreener App
1.54
0.00%
0.00
After Hours:
1.57
0.03
+1.95%
Strata Skin Sciences Inc stock is traded at $1.54, with a volume of 98,519.
It is up +0.00% in the last 24 hours and down -1.91% over the past month.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
See More
Previous Close:
$1.54
Open:
$1.51
24h Volume:
98,519
Relative Volume:
0.04
Market Cap:
$6.42M
Revenue:
$33.36M
Net Income/Loss:
$-10.83M
P/E Ratio:
-4.9677
EPS:
-0.31
Net Cash Flow:
$-5.54M
1W Performance:
-18.95%
1M Performance:
-1.91%
6M Performance:
-39.13%
1Y Performance:
-45.39%
1-Day Range:
$1.50
$1.54
1-Week Range:
$1.50
$1.97
52-Week Range:
$1.38
$3.86
Strata Skin Sciences Inc Stock (SSKN) Company Profile
Name
Strata Skin Sciences Inc
Sector
Industry
Phone
215-619-3200
Address
5 WALNUT GROVE DRIVE, HORSHAM, PA
Compare SSKN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SSKN
Strata Skin Sciences Inc
|
1.54 | 8.11M | 33.36M | -10.83M | -5.54M | -0.31 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Strata Skin Sciences Inc Stock (SSKN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-19 | Initiated | Ladenburg Thalmann | Buy |
| Nov-21-19 | Initiated | Oppenheimer | Outperform |
| Dec-10-18 | Initiated | Northland Capital | Outperform |
| May-16-17 | Reiterated | Rodman & Renshaw | Buy |
| Feb-21-17 | Resumed | Rodman & Renshaw | Buy |
Strata Skin Sciences Inc Stock (SSKN) Latest News
What recovery options are there for STRATA Skin Sciences Inc.Bond Market & Fast Entry and Exit Trade Plans - newser.com
What sentiment indicators say about STRATA Skin Sciences Inc. stockWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Will STRATA Skin Sciences Inc. stock maintain momentum in 20252025 Institutional Moves & Accurate Trade Setup Notifications - newser.com
What institutional flow reveals about STRATA Skin Sciences Inc.Product Launch & Accurate Technical Buy Alerts - newser.com
Relative strength of STRATA Skin Sciences Inc. in sector analysisJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com
Using R and stats models for STRATA Skin Sciences Inc. forecastingQuarterly Portfolio Summary & Proven Capital Preservation Tips - newser.com
Will STRATA Skin Sciences Inc. price bounce be sustainableJobs Report & Verified Swing Trading Watchlist - newser.com
Is STRATA Skin Sciences Inc. reversing from oversold territoryBuy Signal & Low Risk High Reward Ideas - newser.com
What drives STRATA Skin Sciences Inc stock priceSector Leadership Analysis & Double Digit Wealth Tips - earlytimes.in
Risk adjusted return profile for STRATA Skin Sciences Inc. analyzedJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
STRATA Skin Sciences Inc (SSKN) Shares: Cheap or Risky? - fostersleader.com
STRATA Study Shows Excimer Laser Plus Tacrolimus Boosts Psoriasis Outcomes - MSN
STRATA Highlights Excimer Laser as Effective Option for Atopic Dermatitis - MyChesCo
Is STRATA Skin Sciences Inc. stock poised for growthPortfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com
Real time alert setup for STRATA Skin Sciences Inc. performanceWeekly Stock Analysis & Community Verified Trade Signals - newser.com
Price action breakdown for STRATA Skin Sciences Inc.July 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
Strata Skin Sciences highlights excimer laser efficacy for eczema By Investing.com - Investing.com Nigeria
Marking Eczema Awareness Month – Clinical Research - GlobeNewswire
Strata Skin Sciences highlights excimer laser efficacy for eczema - Investing.com
STRATA Skin Sciences Highlights Efficacy of XTRAC® Excimer Laser in Treating Atopic Dermatitis During Eczema Awareness Month - Quiver Quantitative
Marking Eczema Awareness MonthClinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis - The Manila Times
Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis - GlobeNewswire
16.5M Adults: STRATA's XTRAC® and AMA Indication Expansion Enables Reimbursement for Atopic Dermatitis - Stock Titan
Applying chart zones and confluence areas to STRATA Skin Sciences Inc.Global Markets & Community Shared Stock Ideas - newser.com
Strata Skin Sciences highlights new study validating Xtrac laser plus topical drug combo - MarketScreener
STRATA Skin Sciences Receives Continued Validation for its - GlobeNewswire
STRATA Skin Sciences Receives Continued Validation for its Personalized Approach with New Published Study Highlighting XTRAC® Excimer Laser Treatment Combined with a Topical Drug in Psoriasis - The Manila Times
STRATA Skin Sciences Announces Publication of Study Highlighting Enhanced Efficacy of XTRAC Laser in Combination with Tacrolimus for Plaque-Type Psoriasis Treatment - Quiver Quantitative
82% Psoriasis Score Improvement: STRATA's XTRAC Laser Combo Therapy Outperforms Standard Treatment - Stock Titan
Momentum divergence signals in STRATA Skin Sciences Inc. chartJuly 2025 Pullbacks & Weekly High Potential Stock Alerts - newser.com
How hedge fund analytics apply to STRATA Skin Sciences Inc. stockPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Is STRATA Skin Sciences Inc a good long term investmentAnalyst Downgrades & Free High Yield Growth Strategies - earlytimes.in
STRATA Skin Sciences Study Shows Breakthrough in Vitiligo Combination Therapy - MyChesCo
Strata Skin Sciences Inc Stock (SSKN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):